BDIX |
percentage of study population displaying trigeminal nerve neurilemmomas at a point in time |
N-ethyl-N-nitrosourea (80 ug/g) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
trigeminal nerve integrity trait |
male |
200 days
| 57 |
|
|
55.0 |
% |
0.89 |
6.75 |
in vivo visual assessment |
0.0 |
|
0 |
|
inferred from Kaplan-Meier plot analysis |
SD approximated from 95%CI |
98142 |
2018 |
BDIX |
percentage of study population displaying trigeminal nerve neurilemmomas at a point in time |
N-ethyl-N-nitrosourea (80 ug/g) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
trigeminal nerve integrity trait |
both |
200 days
| 109 |
|
|
49.0 |
% |
0.48 |
5.0 |
in vivo visual assessment |
0.0 |
|
0 |
|
inferred from Kaplan-Meier plot analysis |
SD approximated from 95%CI |
98144 |
2018 |
BDIX |
post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors |
N-ethyl-N-nitrosourea (80 mg/kg) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
life span trait |
male |
181 days-213 days |
57 |
Kaplan Meier estimate |
median |
197.0 |
d |
1.06 |
8.0 |
necropsy |
0.0 |
|
0 |
|
|
SD approximated from 95%CI |
98125 |
2018 |
BDIX |
percentage of study population displaying trigeminal nerve neurilemmomas at a point in time |
N-ethyl-N-nitrosourea (80 ug/g) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
trigeminal nerve integrity trait |
female |
200 days
| 52 |
|
|
41.0 |
% |
1.07 |
7.75 |
in vivo visual assessment |
0.0 |
|
0 |
|
inferred from Kaplan-Meier plot analysis |
SD approximated from 95%CI |
98143 |
2018 |
BDIX |
post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors |
N-ethyl-N-nitrosourea (80 mg/kg) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
life span trait |
both |
190 days-213 days |
109 |
Kaplan Meier estimate |
median |
201.0 |
d |
0.55 |
5.75 |
necropsy |
0.0 |
|
0 |
|
|
SD approximated from 95%CI |
98127 |
2018 |
BDIX |
ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time |
N-ethyl-N-nitrosourea (80 mg/kg) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
life span trait |
female |
200 days
| 52 |
|
|
59.0 |
% |
1.07 |
7.75 |
in vivo visual assessment |
0.0 |
ENU injection |
200 |
days |
PI time in S1 |
ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873) |
98159 |
2018 |
BDIX |
ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time |
N-ethyl-N-nitrosourea (80 mg/kg) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
life span trait |
both |
200 days
| 109 |
|
|
51.0 |
% |
0.48 |
5.0 |
in vivo visual assessment |
0.0 |
ENU injection |
200 |
days |
PI time in S1 |
ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873) |
98160 |
2018 |
BDIX |
post-insult time of death due to ENU-induced malignant peripheral nerve sheath tumors |
N-ethyl-N-nitrosourea (80 mg/kg) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
life span trait |
female |
192 days-236 days |
52 |
Kaplan Meier estimate |
median |
214.0 |
d |
1.53 |
11.0 |
necropsy |
0.0 |
|
0 |
|
|
SD approximated from 95%CI |
98126 |
2018 |
BDIX |
ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time |
N-ethyl-N-nitrosourea (80 mg/kg) |
van den Berg L, et al., Int J Cancer. 2015 May 1;136(9):2099-108. doi: 10.1002/ijc.29256. Epub 2014 Oct 28. |
life span trait |
male |
200 days
| 57 |
|
|
45.0 |
% |
0.66 |
5.0 |
in vivo visual assessment |
0.0 |
ENU injection |
200 |
days |
PI time in S1 |
ratio of survivors of malignant peripheral nerve sheath tumors to total study population during a period of time (CMO:0003873) |
98158 |
2018 |